BeOne Medicines Ownership | Who Owns BeOne Medicines?


OverviewForecastRevenueFinancialsChartTranscripts

BeOne Medicines Ownership Summary


BeOne Medicines is owned by 31.52% institutional investors, 17.28% insiders, and 51.20% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 7.93% of ONC shares. Capital Group New Perspective Comp is the top mutual fund, with 2.39% of its assets in BeOne Medicines shares.

ONC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBeOne Medicines31.52%17.28%51.20%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustryBiotech Stocks 49.09%12.06%38.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp8.80M7.93%$2.51B
Primecap management co/ca/5.01M4.51%$1.43B
Capital investors4.21M3.79%$1.20B
Fmr2.48M2.23%$706.31M
Capital world investors2.25M2.03%$641.06M
Thomas j. herzfeld advisors2.05M1.86%$29.00M
Citadel advisors1.43M1.28%$406.23M
Temasek (private)845.73K0.76%$241.01M
Price t rowe associates inc /md/758.75K0.68%$216.22M
Blackrock funding, inc. /de694.62K0.63%$197.95M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Baker bros. advisors lp8.80M12.57%$2.51B
Thomas j. herzfeld advisors2.05M9.81%$29.00M
Patient square capital lp90.02K3.97%$25.65M
Nan fung group15.72K3.41%$4.48M
Healthinvest partners ab35.18K2.70%$10.03M
Siren465.00K2.68%$132.51M
Superstring capital management lp12.27K2.21%$3.50M
Jgp global gestao de recursos ltda.1.71K1.08%$487.58K
North ground capital135.32K0.95%$1.91M
Slow capital28.24K0.94%$8.05M

Top Buyers

HolderShares% AssetsChange
Thomas j. herzfeld advisors2.05M9.81%2.05M
Capital world investors2.25M0.08%626.89K
Citadel advisors1.43M0.05%393.22K
Millennium management543.32K0.06%338.48K
Two sigma investments, lp286.55K0.06%253.01K

Top Sellers

HolderShares% AssetsChange
Fmr2.48M0.03%-1.22M
Hhlr advisors---1.03M
Ubs group258.59K0.01%-156.74K
Driehaus capital management35.50K0.06%-119.50K
Virtu financial---80.46K

New Positions

HolderShares% AssetsChangeValue
Thomas j. herzfeld advisors2.05M9.81%2.05M$29.00M
North ground capital135.32K0.95%135.32K$1.91M
Lansforsakringar fondforvaltning ab (publ)123.35K0.01%123.35K$2.68M
Arete wealth advisors99.33K0.09%99.33K$1.40M
Resources investment advisors, llc.97.13K0.01%97.13K$1.37M

Sold Out

HolderChange
Albion financial group /ut-1.00
Hm payson-2.00
Westside investment management-2.00
Twin peaks wealth advisors-2.00
Root financial partners-3.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026294-0.68%34,973,1370.45%313.09%17123.91%66-32.65%
Mar 31, 2026290-19.22%34,397,333-32.01%311.50%136-41.38%9734.72%
Dec 31, 2025154-44.80%12,358,898-62.55%111.25%87-43.87%40-48.72%
Sep 30, 202527910.71%32,997,831-4.21%292.97%15530.25%78-8.24%
Jun 30, 2025252-8.70%34,449,266-19.00%312.01%119-21.71%858.97%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Capital Group New Perspective Comp2.66M2.39%-
American Funds New Perspective A2.66M2.39%-
Vanguard PRIMECAP Inv2.35M2.11%28.00K
Vanguard Capital Opportunity Inv1.18M1.06%12.50K
NT Emerg Markets Index Fund - NL824.27K0.74%-41.00K
Fidelity Growth Compy Commingled Pl S828.16K0.73%-
American Funds EUPAC A700.82K0.63%-29.57K
Capital Group EUPAC Composite700.82K0.63%-29.57K
Fidelity Contrafund698.37K0.63%-36.93K
American Funds New World A677.29K0.61%14.74K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 11, 2026Lee Chan Henry SVP, General CounselSell$959.76K
Aug 10, 2026OYLER JOHN Chief Executive OfficerSell$23.45K
Aug 10, 2026OYLER JOHN Chief Executive OfficerSell$1.30M
Aug 10, 2026OYLER JOHN Chief Executive OfficerSell$989.60K
Aug 10, 2026OYLER JOHN Chief Executive OfficerSell$2.38M

Insider Transactions Trends


DateBuySell
2026 Q3-90
2026 Q2-40
2026 Q1-4
2025 Q4-47
2025 Q3-42

ONC Ownership FAQ


Who Owns BeOne Medicines?

BeOne Medicines shareholders are primarily institutional investors at 31.52%, followed by 17.28% insiders and 51.20% retail investors. The average institutional ownership in BeOne Medicines's industry, Biotech Stocks , is 49.09%, which BeOne Medicines falls below.

Who owns the most shares of BeOne Medicines?

BeOne Medicines’s largest shareholders are Baker bros. advisors lp (8.8M shares, 7.93%), Primecap management co/ca/ (5.01M shares, 4.51%), and Capital investors (4.21M shares, 3.79%). Together, they hold 16.24% of BeOne Medicines’s total shares outstanding.

Does Blackrock own BeOne Medicines?

BlackRock is not among the top 10 institutional shareholders of BeOne Medicines.

Who is BeOne Medicines’s biggest shareholder by percentage of total assets invested?

Baker bros. advisors lp is BeOne Medicines’s biggest shareholder by percentage of total assets invested, with 12.57% of its assets in 8.8M BeOne Medicines shares, valued at 2.51B$.

Who is the top mutual fund holder of BeOne Medicines shares?

Capital Group New Perspective Comp is the top mutual fund holder of BeOne Medicines shares, with 2.39% of its total shares outstanding invested in 2.66M BeOne Medicines shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools